Prolonged large bowel transit increases serum deoxycholic acid: A risk factor for octreotide induced gallstones

Gut

Volumn 44, Issue 5, 1999, Pages 675-681

  Veysey, M J ^a   Thomas, L A ^a   Mallet, A I ^b   Jenkins, P J ^c   Besser, G M ^c   Wass, J A H ^d   Murphy, G M ^a   Dowling, R H ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Acromegaly; Deoxycholic acid; Gallstones; Large bowel transit time; Mouth to caecum transit time; Octreotide

Indexed keywords

DEOXYCHOLIC ACID; OCTREOTIDE;

ACROMEGALY; ADULT; AGED; ARTICLE; BILE ACID SYNTHESIS; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIET RESTRICTION; DRUG MECHANISM; FEMALE; GALLSTONE FORMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE TRANSIT TIME; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0033005301     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.5.675     Document Type: Article

References (44)

1. 1 Ho KY, Weissberger AJ, Marbach P, et al. Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Ann Intern Med 1990;112:173-81.
2. 2 Newman CB, Melmed S, Snyder PJ, et al. Safety and efficacy of long term octreotide therapy of acromegaly. results of a multicenter trial in 103 patients - a clinical research center study. J Clin Endocrinol Metab 1995;80: 2768-75.
3. 3 Redfern JS, Fortuner WJ II. Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management. Am J Gastroenterol 1995;90:1042-52.
4. 4 Dowling RH, Hussaini SH, Murphy GM, et al. Gallstones during octreotide therapy. Metabolism 1992;41(suppl 2): 22-33.
5. 5 Hussaini SH, Pereira SP, Veysey MJ, et al. The roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide-induced gallbladder stones. Gut 1996;38: 775-83.
6. 6 Stolk MFJ, van Erpecum KJ, Koppeschaar HPF, et al. Postprandial gallbladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly. Gut 1993;34:808-13.
7. 7 van Liessum PA, Hopman WP, Pieters GF, et al. Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analogue SMS 201-955 in acromegaly. J Clin Endocrinol Metab 1989,69:557-62.
8. 8 Ewins DL, Javaid A, Coskeran PB, et al. Assessment of gallbladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. Q J Med 1992;83:295-306.
9. 9 Catnach SM, Anderson JV, Fairclough PD, et al. The effect of octreotide on gallstone prevalence and gallbladder motility in acromegaly. Gut 1993;34:270-3.
10. 10 Hussaini SH, Murphy GM, Kennedy C, et al. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Gastroenterology 1994;107:1503-13.
11. 11 Marcus SN, Heaton KW. Deoxycholic acid and the pathogenesis of gallstones. Gut 1988;29:522-33.
12. 12 Hill MJ, Drasar BS. Degradation of bile salts by human intestinal bacteria. Gut 1968;9:22-7.
13. 13 Midtvedt T. Microbial bile acid transformation. Am J Clin Nutr 1974;27:1341-7.
14. 14 Morris JS, Heaton KW, Read AE. Absorption of bile acids by the colon [abstract]. Gut 1970;11:1063.
15. 15 Samuel P, Saypol GM, Meilman E, et al. Absorption of bile acids from the large bowel in man. J Clin Invest 1968;47:2070-8.
16. 16 Marcus SN, Heaton KW. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile: three inter-related factors. Gut 1986;27:550-8.
17. 17 Fuessl HS, Carolan G, Williams G, et al. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man. Digestion 1987;36: 101-7.
18. 18 Lembcke B, Creutzfeldt W, Schlesser R, et al. Effect of somatostatin analogue (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal man. Digestion 1987;36:108-24.
19. 19 Møller N, Petrany G, Cassidy D, et al. Effects of somatostatin analogue SMS 201-955 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man. Clin Sci 1988;750:345-50.
20. 20 O'Donnell LJD, Watson AJM, Cameron D, et al. Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome. Aliment Pharmacol Ther 1990;4:177-82.
21. 21 Trainer PJ, Besser M. Acromegaly. In: The Bart's endocrine protocols. London: Churchill Livingstone, 1995:80-1.
22. 22 Bond JH, Levitt MD. Investigation of small bowel transit time in man utilizing pulmonary hydrogen measurements. J Lab Clin Med 1974;85:546-56.
23. 23 Metcalf AM, Phillips SF, Zinsmeister AR, et al. Simplified assessment of segmental colonic transit. Gastroenterology 1987;92:40-7.
24. 24 Setchell KDR, Worthington J. A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phase octadecylsilane bonded silica cartridges. Clin Chim Acta 1982; 125:135-44.
25. 25 Setchell KDR, Matsui A. Serum bile acid analysis. Clin Chim Acta 1983;127:1-17.
26. 26 Nair PP. Enzymatic cleavage of bile acid conjugates. In: Schiff L, Carey JB, Dietschy J, eds. Bile salt metabolism. Springfield, IL: Charles Thomas Publishers, 1969:172-83.
27. 27 Dyfverman A, Sjövall J. A novel liquid-gel chromatographic method for extraction of unconjugated steroids from aqueous solutions. Anal Lett 1978;B11:485-99.
28. 28 Goto J, Watanabe K, Miura H, et al. Trace analysis of bile acids by gas chromatography-mass spectrometry with negative ion chemical ionization detection. J Chromatogr 1987;388:379-87.
29. 29 Stellaard F, Langelaar A, Kok RM, et al. Determination of plasma bile acids by capillary gas-liquid chromatography-electron capture negative chemical ionization mass fragmentography. J Lipid Res 1989;30:1647-52.
30. 30 Strasberg SM, Harvey PR, Hofmann AF. Bile sampling, processing and analysis in clinical studies. Hepatology 1990; 12(suppl):176-80S.
31. 31 Swobodnik W, Hagert N, Janowitz P, et al. Diagnostic fine needle puncture of the gallbladder with US guidance. Radiology 1991;178:755-8.
32. 32 Hussaini SH, Kennedy C, Pereira SP, et al. Ultrasound guided percutaneous fine needle puncture of the gallbladder for studies of bile composition. Br J Radiol 1995;68:271-6.
33. 13C] deoxycholic acid and serum sampling. J Lipid Res 1986;27:1222-5.
34. 34 Nagengast FM, van Munster IP, Salemans JMJI. Deoxycholic acid metabolism in patients with adenomas. Gastroenterology 1993;105:955-6.
35. 35 Veysey MJ, Gathercole DJ, Mallet A, et al. Large bowel transit time influences deoxycholic acid input rate and pool size - risk factors for octreotide-induced gallstones [abstract]. Gastroenterology 1997;112:A525.
36. 36 van der Ohe MR, Camilleri M, Thomforde GM, et al. Differential regional effects of octreotide on human gastrointestinal motor function. Gut 1995;36:743-8.
37. 37 Shoda J, He BF, Tanaka N, et al. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo synthesis of cholesterol and bile acids in the liver, gallbladder emptying and small intestinal transit. Hepatology 1995;21:1291-302.
38. 38 Azzaroli F, Mazzella G, De Vergori E, et al. Sluggish gallbladder and small bowel motility are associated with cholesterol gallstones [abstract]. Gastroenterology 1997;112: A499.
39. 39 Dowling RH, Veysey MJ, Pereira SP, et al. Role of intestinal transit in the pathogenesis of cholesterol gallstones. Can J Gastroenterol 1997;11:57-64.
40. 40 Heaton KW, Emmett PM, Symes CL, et al. An explanation for gallstones in normal weight women: slow intestinal transit. Lancet 1993;341:8-10.
41. 41 Berr F, Kullak-Ublick GA, Paumgartner G, et al. 7α-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology 1996;111:1611-20.
42. 42 Thomas LA, Bathgate T, Veysey MJ, et al. Is cholelithiasis an intestinal disease [abstract]? Gut 1997;41(suppl 3):A2.
43. 43 El Oufir L, Flourie B, Bruley des Varannes S, et al. Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut 1996;38:870-7.
44. 44 Lewis S, Heaton K. Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut 1997;41: 245-51.